Skip to main content
. 2021 Apr 20;59(5):e02890-20. doi: 10.1128/JCM.02890-20

FIG 4.

FIG 4

Detection rates by 10 commercial immunoassays (6 ELISAs, 3 CLIAs, one rapid test; all with a specificity >80%) in the 354 blood samples from 81 hospitalized IgG-seroconverting patients with acute SARS-CoV-2 infection, grouped by a 2-day interval (one sample per patient per interval step). (A) IgM ELISAs; (B) IgA ELISA; (C) IgG ELISAs/CLIAs; (D) total Ig ELISAs/CLIAs and rapid tests. Borderline results were counted as negative.